Beck H, Shokouh-Amiri M H, Christiansen L A
Acta Pathol Microbiol Immunol Scand A. 1987 Jan;95(1):35-9. doi: 10.1111/j.1699-0463.1987.tb00007_95a.x.
In a prospective study, 20 patients with endoscopically proven duodenal ulcers were randomised to be treated with cimetidine 1 g daily or with antacids 350 mmol daily. The duration of treatment was 30 days, but this was extended to three months in 3 patients in the cimetidine group and 4 patients in the antacid group. A morphological study of biopsies taken via a gastroscope from the corpus mucosa showed no change in mucosal height, parietal cell density per unit volume or changes in cellular infiltration after 30 and 90 days treatment in the two groups. Neither H-2 receptor blockers nor antacids alter mucosal height or parietal cell density. Treatment was not found to induce gastritic changes in the mucosa.
在一项前瞻性研究中,20例经内镜证实的十二指肠溃疡患者被随机分为两组,一组每日服用1克西咪替丁,另一组每日服用350毫摩尔抗酸剂。治疗期为30天,但西咪替丁组有3例患者、抗酸剂组有4例患者的治疗期延长至三个月。通过胃镜从胃体黏膜获取活检组织进行形态学研究,结果显示,两组在治疗30天和90天后,黏膜高度、单位体积壁细胞密度均无变化,细胞浸润情况也无改变。H-2受体阻滞剂和抗酸剂均未改变黏膜高度或壁细胞密度。未发现治疗会诱发胃黏膜发生胃炎样改变。